News
President Trump could have walked softly and carried a big stick. As pharmaceutical investors see it, he instead stomped ...
Global pharmaceutical shares jumped in intraday trading Monday, reversing their pre-market declines, as investors anticipated ...
Collegium Pharmaceutical (COLL) said it has entered into an accelerated share repurchase agreement ((ASR)) with Jefferies to buy back $25 million of its stock.
Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) were sinking 11.9% as of 10:18 a.m. ET on Tuesday. The sharp decline came after the company announced its 2025 first-quarter results on Monday evening.
The 4 generic pharmaceuticals stocks we track reported a slower Q4. As a group, revenues beat analysts’ consensus estimates by 2.2%. Amidst this news, share prices of the companies have had a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results